INSL5 | Insulin-like 5 | Predicted secreted proteins
| | | | | Group enriched |
DEFA5 | Defensin, alpha 5, Paneth cell-specific | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
DEFA6 | Defensin, alpha 6, Paneth cell-specific | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
CYP3A4 | Cytochrome P450, family 3, subfamily A, polypeptide 4 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
C17orf78 | Chromosome 17 open reading frame 78 | Predicted membrane proteins
| | | | | Group enriched |
GIP | Gastric inhibitory polypeptide | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
RBP2 | Retinol binding protein 2, cellular | Transporters
| | | | | Group enriched |
SLC5A5 | Solute carrier family 5 (sodium/iodide cotransporter), member 5 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
HOXB13 | Homeobox B13 | Transcription factors
| | | | | Group enriched |
CLDN18 | Claudin 18 | Predicted membrane proteins
| | | | | Group enriched |
SLC34A3 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
APOA4 | Apolipoprotein A-IV | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
MEP1A | Meprin A, alpha (PABA peptide hydrolase) | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CPS1 | Carbamoyl-phosphate synthase 1, mitochondrial | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Group enriched |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
KHK | Ketohexokinase (fructokinase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
MEP1B | Meprin A, beta | Enzymes Predicted membrane proteins
| | | | | Group enriched |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
TFF2 | Trefoil factor 2 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
MALRD1 | MAM and LDL receptor class A domain containing 1 | Predicted membrane proteins
| | | | | Group enriched |
NOX1 | NADPH oxidase 1 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
XPNPEP2 | X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound | Enzymes Predicted secreted proteins
| | | | | Group enriched |
ALDOB | Aldolase B, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
MUC12 | Mucin 12, cell surface associated | Predicted membrane proteins
| | | | | Group enriched |
NLRP6 | NLR family, pyrin domain containing 6 | Plasma proteins
| | | | | Group enriched |
CYP4F2 | Cytochrome P450, family 4, subfamily F, polypeptide 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
TM4SF4 | Transmembrane 4 L six family member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SI | Sucrase-isomaltase (alpha-glucosidase) | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
TREH | Trehalase (brush-border membrane glycoprotein) | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
ENPP7 | Ectonucleotide pyrophosphatase/phosphodiesterase 7 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
GUCA2A | Guanylate cyclase activator 2A (guanylin) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
MUC6 | Mucin 6, oligomeric mucus/gel-forming | Predicted secreted proteins
| | | | | Group enriched |
PYY | Peptide YY | Predicted secreted proteins
| | | | | Group enriched |
VSIG1 | V-set and immunoglobulin domain containing 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
IGFALS | Insulin-like growth factor binding protein, acid labile subunit | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
NXPE1 | Neurexophilin and PC-esterase domain family, member 1 | Predicted membrane proteins
| | | | | Group enriched |
TMEM82 | Transmembrane protein 82 | Predicted membrane proteins
| | | | | Group enriched |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CHST5 | Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CTSE | Cathepsin E | Enzymes Predicted secreted proteins
| | | | | Group enriched |
DHRS11 | Dehydrogenase/reductase (SDR family) member 11 | | | | | | Group enriched |
FABP2 | Fatty acid binding protein 2, intestinal | Cancer-related genes Plasma proteins
| | | | | Group enriched |
PRAP1 | Proline-rich acidic protein 1 | Predicted secreted proteins
| | | | | Group enriched |
SLC5A1 | Solute carrier family 5 (sodium/glucose cotransporter), member 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
VIL1 | Villin 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Group enriched |